PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 9446204

[Cholesterol embolisms].

R Thurnheer·M Riederer
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

CapillariesEmbolism, CholesterolHumansInfarctionIntracranial Embolism and ThrombosisKidneyMaleMiddle AgedMyocardial InfarctionSkinCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Thurnheer, M Riederer. 1997-11-01. [Cholesterol embolisms].. https://pubmed.ncbi.nlm.nih.gov/9446204/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

Expression of IFN-inducible T cell alpha chemoattractant by human endothelial cells is cyclosporin A-resistant and promotes T cell adhesion: implications for cyclosporin A-resistant immune inflammation.

IFN-inducible T cell alpha chemoattractant (I-TAC) is a recently discovered member of the CXC chemokine family. It is a potent T cell chemoattractant expressed by IFN-gamma-treated astrocytes, monocytes, keratinocytes, bronchial epithelial cells, and neutrophils. In this study, we show that I-TAC is also expressed by IFN-gamma-treated endothelial cells (EC), both at the mRNA and protein levels. Induction of the I-TAC message is rapid and sustained over 24 h. TNF-alpha does not induce I-TAC mRNA alone, but does act synergistically with IFN-gamma. Blocking Abs to I-TAC, or to its receptor, CXCR3, reduce T cell adhesion to EC monolayers demonstrating that the expressed protein is functional. Finally, the expression of I-TAC by EC is resistant to the immunosuppressive drug cyclosporin A, suggesting that I-TAC may contribute to the chronic immune inflammation characteristic of graft arteriosclerosis.

Capillaries↗